JW Lifescience Corporation (KRX:234080)
12,580
-120 (-0.94%)
Jan 9, 2026, 3:30 PM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 194.8 billion as of January 9, 2026. Its market cap has increased by 14.78% in one year.
Market Cap
194.80B
Enterprise Value
217.85B
Revenue
248.30B
Ranking
n/a
PE Ratio
4.09
Stock Price
12,580.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 194.80B, a decrease of -42.72%. That is a compound annual growth rate of -5.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 194.80B | -2.10% |
| Dec 30, 2025 | 198.98B | 18.11% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.17T |
| ALTEOGEN | 25.35T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.85T |
| Yuhan | 8.55T |
| HLB Co., Ltd. | 7.19T |
| LigaChem Biosciences | 6.38T |